NASDAQ : IBB

iShares Biotechnology ETF

$189.76 USD

$0.25 (0.13%)

Volume
2.05M
Average Volume
1.55M
Market Capitalization
$9.38B
P/E Ratio
Dividend Yield
%
Price Target
Year High
$199.05
Year Low
$128.84
Day High
—
Day Low
—
Payout Ratio
Current Ratio
Company Overview

NASDAQ

Asset Management

Financial Services

IBB

N/A

US

USD

https://www.ishares.com/us/products/239699/ishares-biotechnology-etf

1-800-474-2737

464287556

0001100663

Liquidity Metrics

Sales & Valuation

-$

Profitability

-$

%

%

%

%

P/E Metrics

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Poll Results

About iShares Biotechnology ETF (NASDAQ:IBB) Stock

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector. ...

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

2026-07-12 15:30:01

First Trust NYSE Arca Biotechnology Index Fund offers a more concentrated portfolio with only 30 holdings compared to the 248 positions in iShares Biotechnology ETF iShares Biotechnology ETF is the larger and more established fund, having launched in 2001 and managing $9.6 billion in assets under management First Trust NYSE Arca Biotechnology Index Fund has achieved a higher total return over both one-year and five-year horizons

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

2026-07-10 06:41:28

The iShares U.S. Pharmaceuticals ETF (IHE) offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF (IBB). IBB offers broader diversification, with 248 holdings compared to just 56 for IHE.

3 Healthcare ETFs to Own in a Choppy Stock Market

2026-07-06 14:04:00

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, are worth a look.

Investors Are Rotating Into Healthcare. Here's Why.

2026-07-02 15:55:36

Janus Henderson portfolio manager Dan Lyons discusses why he sees opportunities for market outperformance in the healthcare sector as innovations in biotechnology, pharmaceuticals and medical devices proliferate. Check out our daily newsletter!

SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns

2026-07-02 07:45:01

State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.44% for iShares Biotechnology ETF. iShares' ETF provides concentrated exposure to 248 biotechnology stocks while the SPDR fund holds 59 diverse healthcare names.

Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It

2026-06-29 17:00:00

Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and higher dosing—effectively extends product lifecycles and drives shareholder value.

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

2026-06-29 12:11:05

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, approvals and deal activity adding momentum.

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

2026-06-29 07:20:22

A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.

Frequently Asked Questions

What is the current iShares Biotechnology ETF (IBB) stock price?

iShares Biotechnology ETF(NASDAQ:IBB) stock price is $189.76 in the last trading session. During the trading session, IBB stock reached the peak price of $199.05 while $128.84 was the lowest point it dropped to. The percentage change in IBB stock occurred in the recent session was 0.13% while the dollar amount for the price change in IBB stock was $0.25.

IBB's industry and sector of operation?

The NASDAQ listed IBB is part of Asset Management industry that operates in the broader Financial Services sector.

Who are the executives of IBB?

|
|
|
|
|

How many employees does IBB have?

Number of IBB employees currently stands at None. IBB operates from 400 Howard Street, San Francisco, CA 94105, US.

Link for IBB official website?

Official Website of IBB is: https://www.ishares.com/us/products/239699/ishares-biotechnology-etf

How do I contact IBB?

IBB could be contacted at phone #1-800-474-2737 and can also be accessed through its website. IBB operates from 400 Howard Street, San Francisco, CA 94105, US.

How many shares of IBB are traded daily?

The average number of IBB shares traded daily for last 3 months was 1.55M.

What is the market cap of IBB currently?

The market value of IBB currently stands at $9.38B with its latest stock price at $189.76